Full-Time

Director Quality Radiation

Posted on 7/4/2025

Sotera Health

Sotera Health

1,001-5,000 employees

Outsourced sterilization and lab testing provider.

Compensation Overview

$127k - $216k/yr

+ 401(k) match

Western Springs, IL, USA

In Person

Must be able to travel up to 30%, including international travel.

Category
Biology & Biotech (2)
,
Requirements
  • Bachelor’s Degree or 8 years of experience in quality / sterilization (or related field)
  • Relevant experience in management function (minimum 3 years)
  • Proficiency in the pharmaceutical / medical device industry is preferred
  • Proficiency in auditing and being audited
  • Proficiency in CAPA performance
  • Experience with Quality Systems and applying Regulatory Standards
  • Experience with ISO and FDA regulations
  • Must be able to read, write and speak English
  • Excellent organizational skills
  • Excellent communication skills on all levels
  • Efficient, accurate, works according to plan
  • Flexible
  • Problem-solving attitude
  • High profile commitment to quality
Responsibilities
  • Ensure compliance with global regulatory bodies, including but not limited to FDA, ISO, MHLW/JPAL, USDA and MHRA.
  • Track and understand all applicable Quality regulations that impact Sterigenics operations.
  • Work with local regulatory agencies on new and existing permits, licenses and regulations that impact our operations.
  • Lead programs to ensure continuous operational quality improvement as measured by quality metrics and reported to the appropriate levels of management.
  • Support facilities during internal and external audits and in response to internal and external audit findings.
  • Participate in Management Reviews and monthly data analysis meetings.
  • Provide technical support regarding the quality management system to senior staff and facility management.
  • Ensure the consistent application and maintenance of the Quality Management System across the facilities. Participate or lead the development, review, and approval of appropriate levels of the system.
  • Represent Sterigenics on national standards groups as appropriate.
  • Ensure active participation by the Quality organization with Operations in establishing best- demonstrated practices.
  • Work with customers to resolve problems and achieving productivity gains wherever possible.
  • Work with Operations, Sales and Engineering to justify and implement capital projects and engineering/process changes as required. The responsibility for a successful project includes meeting applicable regulatory and quality system requirements.
  • Work with the applicable sales representatives to support the customers’ needs and to resolve issues in a timely manner.
  • Participate in customer meetings presenting Sterigenics quality processes, projects and results.
  • Participate in the hiring and training of QA staff with the potential to advance into higher positions.
  • Develop and improve training programs that include job function, as well as interpersonal skills and personal development training.
  • Provide input for Quality Manager appraisals to the appropriate General Manager or VP of Operations.
  • Provide input for all disciplinary actions taken on all regional QA employees.
  • Prepare and understand, as required, budgets and financial plans for the Quality organization.  Meet budget responsibilities in QA operating plan.
  • Work with Operations to meet or exceed the fiscal goals of the organization.

Sotera Health provides sterilization and lab testing services to ensure the safety of medical devices, pharmaceuticals, and food products. The company operates through three divisions: Sterigenics, which uses methods like Gamma and X-ray to eliminate contaminants; Nordion, which supplies the Cobalt-60 isotopes needed for irradiation; and Nelson Labs, which performs over 800 microbiological and analytical tests. Unlike many competitors, it offers a fully integrated supply chain by producing its own sterilization sources while maintaining a global network of 63 facilities and labs. Its goal is to protect global health by providing the mission-critical services required to bring safe healthcare products to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Broadview Heights, Ohio

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Sterigenics volumes grew 8% in 2025, driving mid-to-high single-digit growth.
  • Q1 2026 operating margin hit 28.2%, up from 22.4%, via pricing power.
  • Sessa Capital bought $175.8M stake in February 2026, signaling investor confidence.

What critics are saying

  • EPA EtO enforcement and California bans constrain Sterigenics capacity by 2027.
  • Q1 2026 free cash flow plunged to negative $16.73M from $35.6M prior year.
  • Nelson Labs underperforms with low-single-digit growth versus Sterigenics' 8% volumes.

What makes Sotera Health unique

  • Sotera Health integrates Sterigenics, Nordion, and Nelson Labs for end-to-end sterilization and testing.
  • Nordion supplies Cobalt-60 with 70-year reliability for gamma irradiation worldwide.
  • Nelson Labs performs over 900 microbiological and analytical tests across 15 global labs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Education Assistance

Employee Assistance Program (EAP)

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
The Globe and Mail
Mar 24th, 2026
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop

Detailed price information for Capital One Financial Corp (COF-N) from The Globe and Mail including charting and trades.

Intellectia.AI
Mar 23rd, 2026
Sessa Capital buys $175.8M stake in Sotera Health as shares outperform S&P 500

Sessa Capital has acquired an additional 10,630,381 shares of Sotera Health for approximately $175.80 million on 17 February 2026, bringing its quarter-end position value to $206.47 million. The transaction signals strong confidence in the healthcare services company. Sotera Health shares traded at $13.99 on Monday, representing an 18% gain over the past year, slightly outperforming the S&P 500's 15% increase. The company has generated revenue of approximately $1.16 billion and adjusted EBITDA near $600 million. Despite facing litigation and regulatory risks, Sotera Health's sustained growth potential continues attracting long-term investor interest. The substantial investment by Sessa Capital reinforces the company's position within the asset manager's portfolio.

Yahoo Finance
Mar 23rd, 2026
Sessa Capital invests $175M in Sotera Health following 21% stock drop

Sessa Capital purchased 10.63 million shares of Sotera Health in the fourth quarter for an estimated $175.80 million, according to a Securities and Exchange Commission filing dated 17 February. The stake now represents nearly 7% of Sessa Capital's reportable assets under management. Sotera Health provides sterilisation services and laboratory testing for medical device and pharmaceutical industries. The company generated $1.2 billion in revenue and $77.9 million in net income over the trailing twelve months. Despite 20 years of steady growth and adjusted EBITDA approaching $600 million, the stock has declined as investors focus on litigation risks, high leverage and regulatory concerns. The shares currently trade at $13.99, up 18% over the past year, with a market capitalisation of $4.0 billion.

Yahoo Finance
Mar 22nd, 2026
Sotera Health CFO reaffirms 5%–6.5% organic growth for 2026, eyes $500M–$600M free cash flow

Sotera Health's CFO Jon Lyons reaffirmed constant-currency organic growth guidance of 5% to 6.5% for 2026 at the KeyBanc Healthcare Forum. Sterigenics is expected to deliver mid- to high-single-digit growth, whilst Nordion and Nelson Labs will see lower-single-digit growth. The company closed 2025 with 5.2% organic revenue growth, maintaining over 50% EBITDA margins with a 118-basis-point improvement. Weaker Nelson Labs results were offset by stronger Sterigenics volumes of approximately 8%. Management prioritises free cash flow and capital discipline, targeting $500 million to $600 million over three years. Capital expenditure is expected to drop significantly in 2027 as projects complete. Net leverage has improved towards the 2x–3x target, providing flexibility for debt reduction, acquisitions or share buybacks.

Yahoo Finance
Mar 2nd, 2026
Sotera Health up 30% in a year as fund trims $3.6M stake but maintains conviction

Ananym Capital Management sold 217,684 shares of Sotera Health for an estimated $3.60 million in February 2026, according to an SEC filing. Despite the sale, Sotera Health remains a significant holding at 8.65% of Ananym's assets under management. Sotera Health shares were trading at $17.09 as of 17 February 2026, up nearly 30% over the past year and outperforming the S&P 500 by 14.86 percentage points. The company provides sterilisation services and laboratory testing for medical device, pharmaceutical and food industries. Sotera recently reported its 20th consecutive year of revenue growth, with 2025 revenues rising nearly 6% to $1.16 billion. Management has guided for another 5% to 6.5% revenue increase in 2026, with adjusted EBITDA growth of 5.5% to 7%.

INACTIVE